XML 55 R44.htm IDEA: XBRL DOCUMENT
v3.23.3

Fair Value of Financial Instruments - Schedule of Quantitative Information of Fair Value Measurements (Details) - Significant Unobservable Inputs (Level 3) $ in Thousands | Sep. 30, 2023 USD ($) | Dec. 31, 2022 USD ($)
--- | --- | ---
Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 3,091,880 | $ 2,795,444
Equity and Warrant Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 102,057 | 85,966
Market Comparable Companies | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 41,339 | 30,086
Market Comparable Companies | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 16,640 | 12,479
Market Comparable Companies | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 1,086,232 | 903,427
Market Comparable Companies | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 1,151,128 | 967,108
Market Comparable Companies | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 1,768 | 3,006
Market Comparable Companies | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 278,012 | $ 328,393
Market Comparable Companies | Minimum | Hypothetical Market Yield | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1142 | 0.1174
Market Comparable Companies | Minimum | Hypothetical Market Yield | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1156 | 0.1205
Market Comparable Companies | Minimum | Hypothetical Market Yield | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1103 | 0.1471
Market Comparable Companies | Minimum | Hypothetical Market Yield | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1325 | 0.1368
Market Comparable Companies | Minimum | Premium/(Discount) | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.0100) | (0.0075)
Market Comparable Companies | Minimum | Premium/(Discount) | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.0075) | (0.0100)
Market Comparable Companies | Minimum | Premium/(Discount) | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0075 | 0.0075
Market Comparable Companies | Minimum | Premium/(Discount) | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.0075) | (0.0200)
Market Comparable Companies | Minimum | EBITDA Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 11.1 | 12.4
Market Comparable Companies | Minimum | EBITDA Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 11.1 | 12.4
Market Comparable Companies | Minimum | Revenue Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.9 | 0.7
Market Comparable Companies | Minimum | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.8 | 0.6
Market Comparable Companies | Minimum | Tangible Book Value Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.5 | 1.6
Market Comparable Companies | Minimum | Discount for Lack of Marketability | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0453 | 0.0811
Market Comparable Companies | Minimum | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0561 | 0.0811
Market Comparable Companies | Maximum | Hypothetical Market Yield | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2074 | 0.1904
Market Comparable Companies | Maximum | Hypothetical Market Yield | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2025 | 0.1853
Market Comparable Companies | Maximum | Hypothetical Market Yield | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1103 | 0.1471
Market Comparable Companies | Maximum | Hypothetical Market Yield | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1737 | 0.1849
Market Comparable Companies | Maximum | Premium/(Discount) | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0350 | 0.0175
Market Comparable Companies | Maximum | Premium/(Discount) | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0325 | 0.0150
Market Comparable Companies | Maximum | Premium/(Discount) | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0075 | 0.0075
Market Comparable Companies | Maximum | Premium/(Discount) | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0175 | 0.0075
Market Comparable Companies | Maximum | EBITDA Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 11.1 | 12.4
Market Comparable Companies | Maximum | EBITDA Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 11.1 | 12.4
Market Comparable Companies | Maximum | Revenue Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 18.9 | 16.1
Market Comparable Companies | Maximum | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 14.0 | 8.8
Market Comparable Companies | Maximum | Tangible Book Value Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.5 | 1.6
Market Comparable Companies | Maximum | Discount for Lack of Marketability | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2869 | 0.2890
Market Comparable Companies | Maximum | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3050 | 0.3270
Market Comparable Companies | Weighted Average | Hypothetical Market Yield | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1409 | 0.1517
Market Comparable Companies | Weighted Average | Hypothetical Market Yield | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1538 | 0.1521
Market Comparable Companies | Weighted Average | Hypothetical Market Yield | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1103 | 0.1471
Market Comparable Companies | Weighted Average | Hypothetical Market Yield | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1329 | 0.1482
Market Comparable Companies | Weighted Average | Premium/(Discount) | Pharmaceuticals | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0002 | 0.0001
Market Comparable Companies | Weighted Average | Premium/(Discount) | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0038 | 0.0020
Market Comparable Companies | Weighted Average | Premium/(Discount) | Sustainable and Renewable Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0075 | 0.0075
Market Comparable Companies | Weighted Average | Premium/(Discount) | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0014 | (0.0043)
Market Comparable Companies | Weighted Average | EBITDA Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 11.1 | 12.4
Market Comparable Companies | Weighted Average | EBITDA Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 11.1 | 12.4
Market Comparable Companies | Weighted Average | Revenue Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 7.5 | 7.4
Market Comparable Companies | Weighted Average | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 4.1 | 3.4
Market Comparable Companies | Weighted Average | Tangible Book Value Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.5 | 1.6
Market Comparable Companies | Weighted Average | Discount for Lack of Marketability | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2066 | 0.1979
Market Comparable Companies | Weighted Average | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1965 | 0.1897
Market Adjusted OPM Backsolve | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 7,513 | $ 13,795
Market Adjusted OPM Backsolve | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 2,838 | $ 6,934
Market Adjusted OPM Backsolve | Minimum | Market Equity Adjustment | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.8681) | (0.9782)
Market Adjusted OPM Backsolve | Minimum | Market Equity Adjustment | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.7280) | (0.9782)
Market Adjusted OPM Backsolve | Maximum | Market Equity Adjustment | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2591 | 0.1634
Market Adjusted OPM Backsolve | Maximum | Market Equity Adjustment | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1871 | 0.6643
Market Adjusted OPM Backsolve | Weighted Average | Market Equity Adjustment | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.1007) | (0.1669)
Market Adjusted OPM Backsolve | Weighted Average | Market Equity Adjustment | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | (0.0358) | (0.0886)
Discounted Cash Flow | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 28,668 | $ 19,153
Discounted Cash Flow | Minimum | Discount Rate | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.1983 | 0.1772
Discounted Cash Flow | Maximum | Discount Rate | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3214 | 0.3013
Discounted Cash Flow | Weighted Average | Discount Rate | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3056 | 0.2446
Convertible Note Analysis | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 23,491 | $ 20,356
Convertible Note Analysis | Minimum | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.0100 | 0.0100
Convertible Note Analysis | Maximum | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.5000 | 0.5000
Convertible Note Analysis | Weighted Average | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.3526 | 0.3579
Liquidation | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 0 | $ 0
Liquidation | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 24,555 | 1,671
Liquidation | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 6,243 | $ 8,042
Liquidation | Minimum | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.5000 | 0.0500
Liquidation | Minimum | Probability weighting of alternative outcomes | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.2000 | 0.2000
Liquidation | Minimum | Revenue Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.7 | 2.1
Liquidation | Minimum | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 6.2
Liquidation | Minimum | Discount for Lack of Marketability | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.8500 | 0.8500
Liquidation | Minimum | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 90.00
Liquidation | Maximum | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.5000 | 0.8000
Liquidation | Maximum | Probability weighting of alternative outcomes | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.8000 | 0.8000
Liquidation | Maximum | Revenue Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.7 | 2.1
Liquidation | Maximum | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 6.2
Liquidation | Maximum | Discount for Lack of Marketability | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.8500 | 0.8500
Liquidation | Maximum | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 90.00
Liquidation | Weighted Average | Probability weighting of alternative outcomes | Technology | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.5000 | 0.4829
Liquidation | Weighted Average | Probability weighting of alternative outcomes | Lower Middle Market | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.8000 | 0.8000
Liquidation | Weighted Average | Revenue Multiple | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 1.7 | 2.1
Liquidation | Weighted Average | Revenue Multiple | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 6.2
Liquidation | Weighted Average | Discount for Lack of Marketability | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input | 0.8500 | 0.8500
Liquidation | Weighted Average | Discount for Lack of Marketability | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investment company, investment owned, measurement input |  | 90.00
Other | Equity Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 4,419 | $ 3,513
Other | Warrants |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 640 | 6
Debt Investments originated within 6 months | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 394,728 | 392,168
Imminent Payoffs | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | 23,494 | 77,676
Debt Investments Maturing in Less than One Year | Debt Investments |  |
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items] |  |
Investments | $ 102,229 | $ 93,597

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of input used to measure investment owned by investment company. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_InvestmentCompanyInvestmentOwnedFairValueMeasurementInput
Namespace Prefix: | us-gaap_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_InvestmentsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_DebtInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=htgc_EquityAndWarrantInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_MarketApproachValuationTechniqueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=htgc_PharmaceuticalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=htgc_TechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=htgc_SustainableAndRenewableTechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=htgc_LowerMiddleMarketMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputHypotheticalMarketYieldMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputPremiumDiscountNettingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputEbitdaMultipleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRevenueMultipleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputTangibleBookValueMultipleMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_WeightedAverageMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputMarketEquityAdjustmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueDiscountedCashFlowMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_IncomeApproachValuationTechniqueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_MeasurementInputTypeAxis=htgc_MeasurementInputsProbabilityWeightingOfAlternativeOutcomesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=htgc_ValuationTechniqueLiquidationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=htgc_ValuationTechniqueOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=us-gaap_CostApproachValuationTechniqueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=htgc_DebtInvestmentsImminentPayoffsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ValuationTechniqueAxis=htgc_DebtMaturingWithinOneYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |